These various findings lead to the hypothesis that pharmacological activation of KV7.4 may preserve hearing function and prevent OHC loss in ARHL, and possibly other forms of hearing loss related to compromised KV7.4 function. This evidence concerns the gene KCNQ4 and hearing loss disorder.